Plaintiffs in the pelvic mesh litigation have accused a Johnson & Johnson subsidiary of judge-shopping after the company asked a Philadelphia judge to recuse from an upcoming trial and also sought to have its appeal of a $13 million verdict assigned to a different appellate panel.
The new allegations come as the state appellate courts are beginning to wade into jurisdictional questions sparked by the U.S. Supreme Court’s Bristol-Myers Squibb v. Superior Court of California ruling, which could significantly shrink the pelvic litigation in Philadelphia and alter the city’s broader mass tort landscape.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
